Skip to main content

McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

McKesson Ventures’ managing director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance, and who are recognized as leaders by portfolio company CEOs, industry peers and colleagues.

For two decades, Schulte has been investing in innovative healthcare technology and services businesses focused on improving data insights, health outcomes, and access to care. Schulte joined McKesson Ventures in 2014 as a managing director after 10 years leading Kaiser Permanente Ventures. He took the helm of McKesson Ventures in 2020, from Tom Rodgers, McKesson EVP and Chief Strategy Officer, and now leads one of the most respected and diverse investment teams in healthcare venture.

“This recognition underscores the success of our fund and appreciation for the value of partnering with McKesson Ventures,” Schulte said. “I am proud of the team we have built, the entrepreneurs we have supported and the impact that we have had on healthcare innovation. We have never been more optimistic about the potential for entrepreneurial companies to advance health outcomes and our ability to help them succeed.”

During his tenure at McKesson Ventures, Schulte has helped build out one of the industry’s strongest pharma services portfolios, which include his investments in Komodo Health, Shyft Analytics (acquired by Medidata) and Saama. In addition, he has also led investments in several other category-defining businesses in value-based care including Aledade and Landmark (acquired by Optum).

Schulte began his career in investment banking at JP Morgan, Piper Jaffray, and UBS. He is a graduate of St. John’s University and received a Masters in Public Policy from Harvard Kennedy School.

About McKesson Ventures

McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage digital health and tech-enabled healthcare services companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. healthcare landscape. McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Visit www.mckessonventures.com to learn more.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  261.06
+0.00 (0.00%)
AAPL  309.90
+0.00 (0.00%)
AMD  479.18
+0.00 (0.00%)
BAC  62.43
+0.00 (0.00%)
GOOG  343.34
+0.00 (0.00%)
META  570.05
+0.00 (0.00%)
MSFT  491.71
+0.00 (0.00%)
NVDA  213.05
+0.00 (0.00%)
ORCL  144.76
+0.00 (0.00%)
TSLA  350.25
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.